Report #2899428

Received Jun 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MA
Recovered: Unknown
Vaccinated: Apr 6, 2026
Onset: Apr 6, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Z013655	—

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

No side effects or symptoms have been reported; a patient received CAPVAXIVE while improperly stored on 04/06/2026; This spontaneous report was received from a pharmacist and refers to 74-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On 06-Apr-2026, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) INJ 168 mcg/ml, 0.5 mL as prophylaxis by health professional (vaccine scheme, route and anatomical location not provided; lot # Z013655 has been verified to be valid, expiration date reported and established as: 11-Aug-2027), while improperly stored. Temperature 15.3C. Time frame 720 hours 0 minutes 0 seconds. No previous temperature excursion. No side effects or symptoms have been reported. This is one of two reports from the same reporter.